Soren Acquisition Corp. (SORN) vs Translational Development Acquisition Corp. (TDAC)

A side-by-side comparison of Soren Acquisition Corp. and Translational Development Acquisition Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — SORN vs TDAC

growth of $100 · dividends reinvested · last 1y
SORN +1.6% (+1.6%/yr)TDAC +2.7% (+2.7%/yr)TDAC compounded faster over this window
100101102103Start $100$102$103
SORN TDAC

SORN vs TDAC: by the numbers

  • •TDAC is the larger company ($266M vs $264M market cap).
  • •TDAC trades at the lower trailing earnings multiple (42.00 vs 90.93 P/E), one valuation lens rather than an overall verdict.

Metrics side by side

Valuation

MetricSORNTDAC
P/E ratio90.9342.00
P/B ratio151.311.78

Profitability

MetricSORNTDAC
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE183.78%3.70%
ROIC-0.12%-0.84%

Frequently asked

Which has the lower trailing P/E, SORN or TDAC?
TDAC has the lower trailing P/E: SORN trades at 90.93 and TDAC at 42.00. P/E is one valuation measure and does not by itself establish which business is cheaper.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.